Overweight, Obesity, and Late-Life Sarcopenia Among Men With Cardiovascular Disease, Israel
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i

Overweight, Obesity, and Late-Life Sarcopenia Among Men With Cardiovascular Disease, Israel



English

Details:

  • Journal Article:
    Preventing Chronic Disease (PCD)
  • Personal Author:
  • Description:
    Introduction

    Little is known about the association between obesity and sarcopenia — age-related loss of muscle mass and function — among patients with cardiovascular disease. We investigated the association between overweight, obesity, and sarcopenia among community-dwelling men in Israel with cardiovascular disease.

    Methods

    A subset of 337 men (mean age at baseline 56.7 [SD, 6.5]) who previously (1990–1997) participated in the Bezafibrate Infarction Prevention trial underwent a neurovascular evaluation as part of the Bezafibrate Infarction Prevention Neurocognitive Study 15.0 (SD, 3.0) years after baseline and a sarcopenia evaluation 19.9 (SD, 1.0) years after baseline. We applied a multinomial logistic model to estimate odds ratios and 95% CIs for 3 categories of sarcopenia: no evidence of sarcopenia (ie, robust), probable sarcopenia, and sarcopenia.

    Results

    We found sarcopenia among 54.3% of participants with obesity (body mass index [BMI, in kg/m2] ≥30.0), 37.0% of participants who were overweight (25.0 ≤ BMI ≤29.9), and 24.8% of participants with normal weight (BMI 18.5 to 24.9). In a comparison of BMI ≥25.0 and BMI <25.0, adjusting for covariates, the odds ratio of having probable sarcopenia was 3.27 (95% CI, 1.68–6.36) and having sarcopenia was 5.31 (95% CI, 2.50–11.27).

    Conclusion

    We found a positive association between obesity and late-life sarcopenia and suggest that obesity might be an important modifiable risk factor related to sarcopenia among men with cardiovascular disease.

  • Subjects:
  • Source:
  • ISSN:
    1545-1151
  • Pubmed ID:
    33357306
  • Pubmed Central ID:
    PMC7784548
  • Document Type:
  • Volume:
    17
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:
    Filetype[PDF-551.45 KB]

You May Also Like

Checkout today's featured content at stacks.cdc.gov